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Big Data in the Health Sector
Sonja Zillner and Sabrina Neururer
10.1 Introduction
Several developments in the healthcare sector, such as escalating healthcare costs,
increased need for healthcare coverage, and shifts in provider reimbursement
trends, trigger the demand for big data technologies in order to improve the overall
efficiency and quality of care delivery. For instance, the McKinsey Company
(2011) Study indicates a high financial impact of big data applications in the
healthcare domain, of the order of a $300 billion value per year solely for the US.
Similarly impressive numbers are provided by IBM: within the Executive Report of
IBM Global Business Services (Korster and Seider 2010), the authors describe the
healthcare system as highly inefficient, that is, approximately US$ 2.5 trillion is
wasted annually and efficiency can be improved by 35 %. This is in comparison to
other industries the largest opportunity for efficiency improvements. Moreover,
major players are investing in the growth market of medicine for an aging popula-
tion, for instance Google founded a new company Calico to tackle age-related
health problems. In conclusion, big data applications in healthcare have high
future potential and opportunities.
However, to the best of our knowledge, only a limited number of implemented
big data based application scenarios can be found today. Although non-advanced
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healthcare analytics applications—such as analytics for improved accounting,
quality control, or clinical research—are available in a widespread manner, these
applications do not make use of the potential of big data technologies. This is
mainly due to the fact that health data cannot be easily accessed. High investment
and effort is needed to enable efficient health data management and seamless health
data access as the foundation for big data applications. As a consequence, convinc-
ing business cases are difficult to identify as the burden of the initial investment
strongly reduces any profit expectations. In other words, one of the biggest chal-
lenges in the healthcare domain for the realization of big data applications is the fact
that high investments, standards, and frameworks as well as new supporting
technologies are needed in order to make health data available for subsequent big
data analytics applications. Thus, the efficient management and integration of
health data is a key requirement for big data applications in the healthcare domain
that needs to be addressed.
The investigations (Zillner et al. 2014a, b) in this chapter found that the highest
impact of big data applications in the healthcare domain is expected when it
becomes possible to not only rely on one single, but various data sources such
that different aspects from the various domains can be related. Therefore, the
availability and integration of all related health data sources, such as clinical data,
claims, cost and administrative data, pharmaceutical and research data, patient
monitoring data, as well as the health data on the web, is of high relevance.
Health data is a form of “big data” not only because of the sheer volume but also
for its complexity, diversity, and timeliness. Although large volume of structured
data is already available today, the volume of unstructured data, such as biometric
data, text reports, and medical images, will eclipse the whole data volume require-
ments. This is in close relation to the challenge of handling the high variety of
health data, i.e. not only very heterogeneous data, such as images, structured
reports, unstructured notes, etc., require new forms of (pre-) processing but also
the semantics of its various domains, such as financial, administrative, research,
patient or public health, needs to be reflected. The value of big data applications
relies on the identification of convincing business cases. As the impact and success
of healthcare business cases rely on the cooperation of multiple stakeholders with
often diverging points of interests, they become challenging to identify.
10.2 Analysis of Industrial Needs in the Health Sector
The interviews and investigation in this section show that the high-level require-
ments of increased efficiency and quality of healthcare of today are often seen as
opposing. The majority of high-quality health services rely on the analysis of larger
amounts of data and content. This automatically leads to increased cost of care
given that the means for automatic analysis of data, such as big data technologies,
are still missing. However, with big data analytics, it becomes possible to segment
the patients into groups and subsequently determine the differences between patient
180 S. Zillner and S. Neururer
groups. Instead of asking the question “Is the treatment effective?”, it becomes
possible to answer the question “For which patient is this treatment effective?” This
shift from average-based towards individualized healthcare bears the potential to
significantly improve the overall quality of care in an efficient manner. Conse-
quently, any information that could help to improve both the quality and the
efficiency of healthcare at the same time was indicated as most relevant and useful.
High impact insights can only be realized if the data analytics is accomplished
on heterogeneous datasets encompassing data from the clinical, administrative,
financial, and public domain. This requires that the various stakeholders owning1
the data are willing to share their data assets. However, there is a strong competition
between the involved stakeholders of the healthcare industry. It is a competition for
resources and the resources are limited. Each stakeholder is focused on their own
financial interests, which often leads to sub-optimal treatment decisions. Conse-
quently, the patient is currently the one who is suffering most. The interests and
roles of the various stakeholder groups can be summarized as follows:
• Patients have interest in affordable, high quality, and broad coverage of
healthcare. As of today, only very limited data about the patient’s health
conditions is available and patients have only very limited opportunities to
actively engage in the process.
• Hospital operators are trying to optimize their income from medical treat-
ments, i.e. they have a strong interest in improved efficiency of care, such as
automated accounting routines, improved processes, or improved utilization of
resources.
• Clinicians and physicians are interested in more automated and less labour-
intensive routine processes, such as coding tasks, in order to have more time
available for and with the patient. In addition, they are interested in accessing
aggregated, analysed, and concisely presented health data that enables informed
decision-making and high quality treatment decisions.
• Payors, such as governmental or private healthcare insurers. As of today, the
majority of current reimbursement systems manage fee-for-service or Diagnose-
related Group (DRG) based payments using simple IT-negotiation and data
exchange processes between payors and healthcare providers and do not rely
on data analytics. As payors are deciding which health services (i.e. which
treatment, which diagnosis, or which preventative test) will be covered or not,
their position and influence regarding the adoption of innovative treatments and
practices is quite powerful. However, currently only limited and fragmented data
about the effectiveness and value of health services is available; the reasons for
treatment coverage often remain unclear and sometimes seem to be arbitrary.
• Pharmaceuticals, life science, biotechnology, and clinical research: Here the
discovery of new knowledge is the main interest and focus. As of today, the
1 The concept of data ownership influences how and by whom the data can be used. Thus, the term
“ownership of data” is referred to both the possession of and responsibility for information, that is,
the term “ownership of data” implies power as well as control.
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various mentioned domains are mainly unconnected and accomplish their data
analytics on single data sources. By integrating heterogeneous and distributed
data sources, the impact of data analytic solutions is expected to increase
significantly in the future.
• Medical product providers are interested in accessing and analysing clinical
data in order to learn about their own products performance in comparison to
competitors’ products in order to increase revenue and/or improve the own
market position.
To transform the current healthcare system into a preventative, pro-active, and
value-based system, the seamless exchange and sharing of health data is needed.
This again requires effective cooperation between stakeholders. However, today
the healthcare setting is mainly determined by incentives that hinder cooperation.
To foster the implementation and adaption of comprehensive big data applications
in the healthcare sector, the underlying incentives and regulations defining the
conditions and constraints under which the various stakeholders interact and coop-
erate need to be changed.
10.3 Potential Big Data Applications for Health
Analysis of the health sector (Zillner et al. 2014b) shows that several big data
application scenarios exist that aim towards aligning the need of improved quality,
which in general implies increased cost of care, with the need of improved effi-
ciency of care. Common to all identified big data applications is the fact that they all
require a means to semantically describe and align various heterogeneous data
sources, means to ensure high data quality, means that address data privacy and
security, as well as means for data analytics on integrated datasets.
For example, Public Health Analytics applications demonstrate the potential
opportunities as well as associated technical requirements that are associated with
big data technologies. Public health applications rely on the management of
comprehensive and longitudinal health data from chronic (e.g. diabetes, congestive
heart failure) or severe (e.g. cancer) diseases from the specific patient population in
order to aggregate and analyse treatment and outcome data. Gained insights are
very valuable as they help to reduce complications, slow disease progression, as
well as improve treatment outcome. For instance, since 1970 Sweden is continu-
ously investing in public health analytic initiatives leading to 90 registries
that cover today 90 % of all Swedish patient data with selected characteristics
(some cover even longitudinal data) (Soderland et al. 2012). A related study
(PricewaterhouseCoopers (2009)) showed that Sweden has the best healthcare
outcomes in Europe by average healthcare costs (9 % of the gross domestic product
(GDP)). In order to achieve this, health data (which is stored in structured (e.g. lab
reports) as well as unstructured data (e.g. medical reports, medical images)) need to
be semantically enriched (Semantic Data Enrichment) in order to make the implicit
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semantics of health data understandable across the involved organizations and
stakeholders. In addition, a common infrastructure with common standards
allowing for seamless data sharing (Data Sharing) as well as for the physical
integration of multiple data sources into one platform (Data Integration) are
needed. In order to be compliant to the high data security and privacy requirements
that are needed to protect the sensitive nature of longitudinal health data, common
legal frameworks as well as technical means for data anonymization need to be in
place (Data Security and Privacy). Moreover, in order to ensure the comparability
of health datasets, processes ensuring high data quality through the standardized
documentation as well as systematic analysis of health and outcome data of the
specific patient population are required (Data Quality).
In terms of data handling, the other identified application scenarios yield very
similar technical requirements. For instance, Comparative Effectiveness Research
applications aim to compare the clinical and financial effectiveness of interventions
in order to increase the efficiency and quality of clinical care services. To achieve
this, large datasets encompassing clinical data (information about patient charac-
teristics), financial data (cost data), and administrative data (treatments and services
accomplished) are critically analysed in order to identify the clinically most effec-
tive, as well as most cost-effective treatments that work best for particular patients.
Clinical Operation Intelligence applications aim to identify waste in clinical
processes in order to optimize them accordingly. By analysing medical procedures,
performance opportunities, such as improved clinical processes, fine-tuning, and
adaptation of clinical guidelines, can be realized. Other examples are Clinical
Decision Support (CDS) applications seeking to enhance the efficiency and quality
of care operations by assisting clinicians and healthcare professionals in their
decision-making process by enabling context-dependent information access, by
providing pre-diagnostic information or by validating and correcting the data
provided. A further category of scenarios are applications addressing the Secondary
Usage of Health Data that rely on the aggregation, analysis, and concise presenta-
tion of clinical, financial, administrative, as well as other related health data in order
to discover new valuable knowledge, for instance, to identify trends, predict out-
comes, or to influence patient care, drug development, and therapy choices. Finally,
Patient Engagement Applications focus on establishing a platform/patient portal
that fosters active patient engagement in healthcare processes. Any health apps that
run on top of the patient platform rely on the integration of episodic health data
from clinical settings as well as non-episodic data captured by devices to monitor
health-related parameters, such as activity, diet, sleep, or weight.
10.4 Drivers and Constraints for Big Data in Health
The successful realization of big data in health has several drivers and constraints.
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10.4.1 Drivers
The following drivers were identified for big data in the health sector:
• Increased volume of electronic health data: With the increasing adoption of
electronic health record (EHR) technology (which is already the case in the
USA), and the technological progress in the area of next generation sequencing
and medical image segmentation, more and more health data will be available.
• Need for improved operational efficiency: To address greater patient volumes
(aging population) and to reduce very high healthcare expenses, transparency of
the operational efficiency is needed.
• Value-based healthcare delivery: Value-based healthcare relies on the align-
ment of treatment and financial success. In order to gain insights about the
correlation between effectiveness and cost of treatments, data analytics solutions
on integrated, heterogeneous, complex, and large sets of healthcare data are
demanded.
• US legislation: The US Healthcare Reform, also known as Obamacare, fosters
the implementation of EHR technologies as well as health data analytics. These
have a significant impact on the international market for big health data
applications.
• Increased patient engagement: Applications such as “PatientsLikeMe”2 dem-
onstrate the willingness of patients to actively engage in the healthcare process.
• New incentives: The current system incentives enforce “high number” instead
of “high quality” of treatments. Although it is obvious that nobody wants to pay
for treatments that are ineffective, this is still the case in many medical systems.
In order to avoid low-quality reimbursements, the incentives of the medical
systems need to be aligned with outcomes. Several initiatives, such as Account-
able Care Organizations (ACO) (Centers for Medicare and Medicaid Services
2010), or Diagnose-related Groups (DRG) (Ma Ching-To Albert 1994), have
been implemented in order to reward quality instead of quantity of treatments.
10.4.2 Constraints
The constraints for big data in the health sector can be summarized as follows:
• Digitalization of health data: Only a small percentage of health-related data is
available in digital format.
• Lack of standardized health data: The seamless sharing of data requires that
health data across hospitals and patients needs to be captured in a unified
standardized way.
2 http://www.patientslikeme.com/
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• Data silos: Healthcare data is often stored in distributed data silos, which makes
data analytics cumbersome and unstable.
• Organizational silos: Due to missing incentives, cooperation across different
organizations, and sometimes even between departments within one organiza-
tion, is rare and exceptional.
• Data security and privacy: Legal frameworks defining data access, security,
and privacy issues and strategies are missing, hindering the sharing and
exchange of data.
• High investments: The majority of big data applications in the healthcare sector
rely on the availability of large-scale, high-quality, and longitudinal healthcare
data. The collection and maintenance of such comprehensive data sources
requires not only high investments, but also time (years) until the datasets are
comprehensive enough to produce good analytical results.
• Missing business cases and unclear business models: Any innovative tech-
nology that is not aligned with a concrete business case, including associated
responsibilities, is likely to fail. This is also true for big data solutions. Hence,
the successful implementation of big data solutions requires transparency about:
(a) who is paying for the solution, (b) who is benefiting from the solution, and
(c) who is driving the solution. For instance, the implementation of data analyt-
ics solutions using clinical data requires high investments and resources to
collect and store patient data, i.e. by means of an electronic health record
(EHR) solution. Although it seems to be obvious how the involved stakeholder
could benefit from the aggregated datasets, it remains unclear whether the
stakeholder would be willing to pay for, or drive, such an implementation.
10.5 Available Health Data Resources
The healthcare system has several major pools of health data that are held by
different stakeholders/parties:
• Clinical data, which is owned by the provider (such as hospitals, care centres,
physicians, etc.) and encompasses any information stored within the classical
hospital information systems or EHR, such as medical records, medical images,
lab results, genetic data, etc.
• Claims, cost, and administrative data, which is owned by the provider and the
payors and encompasses any datasets relevant for reimbursement issues, such as
utilization of care, cost estimates, claims, etc.
• Research data, which is owned by the pharmaceutical companies, research labs/
academia, and government and encompasses clinical trials, clinical studies,
population and disease data, etc.
• Patient monitoring data, which is owned by patients or monitoring device
producers and encompasses any information related to patient behaviours and
preferences.
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• Health data on the web: websites such as “PatientsLikeMe” are getting more
and more popular. By voluntarily sharing data about rare diseases or remarkable
experiences with common diseases, their communities and users are generating
large sets of health data with valuable content.
The improvement of quality of care can be addressed if the various dimensions
of health data are incorporated in the automated health data analysis. The data
dimensions encompass (a) the clinical data describing the health status and history
of a patient, (b) the administrative and clinical process data, (c) the knowledge
about diseases as well as related (analysed) population data, and (d) the knowledge
about changes. If the data analysis is restricted to only one data dimension, for
example, the administrative and financial data, it will be possible to improve the
already established management and reimbursement processes; however it will not
be possible to identify new standards for individualized treatments. Hence, the
highest clinical impact of big data approaches for the healthcare domain can be
achieved if data from the four dimensions are aggregated, compared, and related.
As each data pool is held by different stakeholders/parties, the data in the health
domain is highly fragmented. However, the integration of the various heteroge-
neous datasets is an important prerequisite of big health data applications and
requires the effective involvement and interplay of the various stakeholders. There-
fore, adequate system incentives, which support the seamless sharing and exchange
of health data, are needed.
10.6 Health Sector Requirements
The Healthcare Sectorial Forum was able to identify and name several require-
ments, which need to be addressed by big data application in the healthcare domain.
In the following, non-technical and technical requirements will be distinguished
between.
10.6.1 Non-technical Requirements
Business-related requirements are called non-technical requirements and embrace
important prerequisites and needs for big health data application, such as the need
for high investments, value-based system incentives, or multi-stakeholder business
cases.
Need for High Investments Due to the large-scale nature of big health data, the
development and maintenance of big data application in the healthcare domain as
well as the datasets themselves require high investments. Big health data applica-
tions mainly rely on large-scale, high quality, and often longitudinal healthcare
data, which require several years of data gathering to establish comprehensive sets
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of data that can be analysed to produce accurate and insightful results. Such high
investments can rarely be defrayed by one single party but needs to engage multiple
stakeholders, which leads directly to the next non-technical requirement.
Multi-stakeholder Business Cases Due to the high investment needs described
above, it is often essential that several different stakeholders cooperate in order to
cover the investment costs. Here the interests of the stakeholders often diverge.
Another important issue is that the main beneficiaries of a solution are often not the
ones that are able or willing to finance a complete solution (e.g. patients). Never-
theless, even though it is often apparent how involved stakeholders could benefit
from a certain big data solution with aggregated datasets of high quality, it often
remains unclear whether those stakeholders are able or willing to drive or pay for
such a solution.
Need for Value-Based System Incentives In order to increase the effectiveness
of medical treatments, it is necessary to avoid low-quality reimbursements. This
means that the current situation of high-number treatments instead of high-quality
treatments needs to be improved. Since nobody wishes to pay for ineffective
treatments, the incentives of health systems need to be well aligned with outcomes
(e.g. performance-based financing and reimbursement systems) and, in addition, the
cooperation between stakeholders needs to be rewarded.
10.6.2 Technical Requirements
Technical requirements are requirements that are related to specific technologies.
They include semantic data enrichment, data integration and sharing, data privacy
and security, as well as data quality. A major prerequisite for big data applications
and analytics is the availability of data in an appropriate digital form. Many
appropriate technologies are available to fulfil and support this requirement
(e.g. speech recognition). Therefore no emphasis is put on data digitalization. The
lack of appropriate digital data in healthcare is mostly caused by the limited
adoption of data digitalization approaches in the everyday routine and familiar
workflows of clinicians.
Semantic Data Enrichment As the IDC market research institute estimates,
approximately 90 % of health data will be available in an unstructured manner in
the upcoming years (Lu¨nendonk GmbH 2013). To facilitate and guarantee seamless
processing of such data, semantic data enrichment is needed. This means that health
data, such as medical reports, images, videos, or communications, need to be
enriched by so-called semantic labels. The major challenge with semantic data
enrichment is that technological progress needs to be achieved with the analysis of
several different types of data.
Data Integration and Sharing In order to avoid data silos or data cemeteries, big
data has to be efficiently integrated from various different data sources and shared
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seamlessly. Currently, the adoption of technology to exchange data is lacking
behind in Europe (Accenture 2012). In the United Kingdom less than 46 % of
healthcare providers perform healthcare information exchanges, and in Germany
and France this rate is even lower (approximately 25 %). This requirement goes
hand in hand with the need for structured or semantically enriched data in order to
make data easily accessible. A major prerequisite for medical research is the
possibility to integrate data from various different sources to obtain a longitudinal
view of the patients’ history.
Data Security and Privacy When talking about processing, integrating, or
sharing medical data, a strong emphasis must be put on data security and privacy.
Medical data is categorized as highly sensitive personal data and therefore protec-
tion from unauthorized access, manipulation, or damage has to be guaranteed.
Hence the nature of big data might bypass established privacy protection
approaches (e.g. when aggregating big data from different data sources). Big health
data applications need to focus even more strongly on data privacy and security. For
instance, anonymization is known to be a popular approach to de-identify health-
related personal data. By aggregating big data from various different data sources,
anonymized data could be unintentionally re-identified. Therefore, existing privacy
enhancing methods need to be evaluated to find out whether they can meet all
privacy requirements even when dealing with big data. If data privacy cannot be
guaranteed by a specific method, this method needs to be adapted in order to satisfy
the need for privacy or new methods and approaches need to be developed. Apart
from the technical challenges, a common international legal framework together
with guidelines needs to be established in order to provide a common basis for
international exchange and integration of health-related big data.
Data Quality High quality of available datasets is a major prerequisite for big
data applications in the healthcare domain. The benefit of an application is strongly
correlated with the quality of the data. In the healthcare domain, the quality of the
available data is often unclear. The frequency of missing or incorrect values is an
indicator of data quality. Usually the quality of data improves when data is captured
and processed using high-quality information technology (IT) tools. Such tools can
be integrated into everyday work routines and perform certain data quality checks
(e.g. plausibility checks) during the data capturing or entering process. In order to
generate valuable results or decision support when analysing health data, big data
applications need to fulfil high quality standards.
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10.7 Technology Roadmap for Big Data in the Health
Sector
The following roadmap outlines and describes technologies and the underlying
research questions, which meet the requirements defined in the previous section.
Figure 10.1 visualizes and aligns them with the specific technical requirements.
10.7.1 Semantic Data Enrichment
In order to semantically enrich medical data a framework needs to be provided.
Therefore, semantic enrichment techniques are needed that go beyond the mere
extraction of relevant information from unstructured text or medical images.
Semantic labels, which express and define the meaning of information, render the
original content semantically accessible as well as automatically processable and
machine-readable. For instance, medical procedure and diagnosis entities in
unstructured text such as medical reports are recognized and the describing pas-
sages are linked. Therefore sophisticated text analysis techniques are needed
(Bretschneider et al. 2013). Furthermore, a standardized enrichment framework,
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Fig. 10.1 Mapping requirements to research questions in the healthcare sector
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semantic enrichment of medical data, advances are needed for the following
technologies:
• Information extraction from medical texts brings up new challenges to
classical information extraction techniques, as negation, temporality, and further
contextual features need to be taken into account. Several studies (Fan and
Friedman 2011; Savova et al. 2010) show advances towards the specials needs
of parsing medical text. As the ongoing research mainly focuses on clinical text
in the English language, adaptations to other European languages are needed.
• Image understanding algorithms to formally capture automatically detected
image information, such as anatomical structures, abnormal structures, and
semantic image annotations, are desired. Therefore, additional research
targeting and considering the complexity of the human body as well as the
different medical imaging technologies is needed.
• Standardized medical annotation frameworks that include standardized med-
ical text processing and support the technical integration of annotation technol-
ogies. Even though there are some frameworks available (e.g. UIMA3),
adaptations are needed in order to meet the specific challenges and requirements
of the healthcare domain.
10.7.2 Data Sharing and Integration
Efficient data integration and seamless sharing relies on standardized coding
schemes and terminologies as well as data models. Currently standardized coding
systems are either used for high-level information coding (e.g. diseases, laboratory
values, medications) or not internationally used. A lot of information is not avail-
able in coded format at all. For the usage of standardized data models, the HL7
Reference Information Model4 (RIM) is considered to become the standard data
model for EHR implementations. Nevertheless a high percentage of technology
providers still rely on their own data models when it comes to data integration. In
order to advance data integration and sharing, coding schemes as well as data
models need to be improved and standardized.
• Semantic data models enable the unambiguous representation of data. Existing
models (e.g. HL7 RIM) have several issues that make it difficult to implement.
Further research activities, such as the Model for Clinical Information (MCI)
(Oberkampf et al. 2013) that integrate patient models on the basis of ontologies,
are ongoing.
• Semantic knowledge models such as biomedical domain ontologies and termi-
nologies are used in combination with semantic data models and help to
3 http://uima.apache.org/
4 http://www.hl7.org/implement/standards/rim.cfm
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facilitate semantic interoperability. There are several different models
(e.g. SNOMED CT5) available, but further research in order to improve these
standards, as well as to develop new standards, is needed.
• Context information is needed in order to provide information about data
provenance, usage, or ownership. Therefore standards for describing context
information are needed.
10.7.3 Data Privacy and Security
In order to fulfil the high demand for big health data privacy and security, different
aspects need to be taken into account. Besides the national data protection laws, a
common legal framework for the European Union is needed in order to facilitate
international approaches or cooperation. When talking about big health data pri-
vacy and security, it is often necessary to re-identify patients (e.g. for longitudinally
assessing the patient’s health status). The aggregation of data from various different
data sources brings up two major challenges for big data privacy and security. First,
the aggregation of data from heterogeneous data sources is difficult and data for
patient has to be aligned properly. Also the nature of big data may bypass certain
privacy enhancing methods when aggregating data from various different data
sources. Therefore advances are needed for the following technologies:
• Hash algorithms are often used as an encryption method. Its one-way function
can also be used to generate pseudo-identifiers and therefore facilitate secure
pseudonymization. However it is crucial that hash algorithms are robust and
collision resistant.
• Secure data exchange across institutional and country boundaries is essential
for several interesting visions for the healthcare domain (e.g. international
EHR). Therefore, Integrating the Healthcare Enterprise (IHE)6 profiles are
widely used (e.g. IHE cross-enterprise document sharing) although they are
still the focus of research activities.
• De-identification algorithms, such as anonymization or pseudonymization,
need to be improved in order to guarantee data privacy even when aggregating
big data from different data sources. K-anonymity (El Emam and Dankar 2008)
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10.7.4 Data Quality
Good data quality is a key-enabler for big health data applications. It depends on
four different aspects: (1) the data quality of the original data sources, (2) the
coverage and level of detail of the collected data, (3) common semantics as
described before, and (4) the handling of media-disruptions. In order to improve
the data quality of these four aspects, advances for the following technologies are
needed:
• An improvement of provenance management is needed in order to allow
reliable curation of health data. Therefore data-level trust and permission man-
agement mechanisms need to be implemented.
• Human-data interaction technologies [e.g. natural language interfaces,
schema–agnostic query formulation (Freitas and Curry 2014)] improve data
quality as they facilitate ease-of-use interaction that is perfectly integrated in
particular workflows.
• Reliable information extraction approaches are needed in order to facilitate
the processing of unstructured medical data (e.g. medical reports, medical
images). Therefore existing approaches (e.g. natural language processing) have
to be improved for the purpose of addressing the specific characteristics of health
information and data.
Roadmap developments are usually accomplished for a single company. There is
a need to develop a roadmap for the European market that depends on (a) the degree
to which the non-technical requirements will be addressed and (b) the extent to
which European organizations are willing to invest in big data developments and
use case implementations. As such it was not possible to come up with an exact
timeline of technology milestones, but with an estimated timeline depicted in
Table 10.1.
10.8 Conclusion and Recommendations for Health Sector
Big data technologies and health data analytics provide the means to address the
efficiency and quality challenges in the health domain. For instance, by aggregating
and analysing health data from disparate sources, such as clinical, financial, and
administrative data, the outcome of treatments in relation to the resource utilization
can be monitored. This analysis in turn helps to improve the efficiency of care.
Moreover, the identification of high-risk patients with predictive models leads
towards proactive patient care allowing for the delivery of high quality care.
A comprehensive analysis of domain needs and requirements indicated that the
highest impact of big data applications in the healthcare domain is achievable when
it becomes possible to not only acquire data from one single source, but various data
sources such that different aspects can be combined to gain new insights. Therefore,
the availability and integration of all related health data sources, such as clinical
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data, claims, cost, and administrative data, pharmaceutical and R&D data, patient
behaviour, and sentiment data as well as the health data on the web, is of high
relevance.
However, access to health data is currently only possible in a very constrained
manner. In order to enable seamless access to healthcare data, several technical
requirements need to be addressed, including (1) the content of unstructured health
data (such as images or reports) is enhanced by semantic annotation; (2) data silos
are conquered by means of efficient technologies for semantic data sharing and
exchange; (3) technical means backed by legal frameworks ensure the regulated
sharing and exchange of health data; and (4) techniques for assessing and improv-
ing data quality are available.
The availability of the technologies will not be sufficient for fostering wide-
spread adoption of big data in the healthcare domain. The critical stumbling block is
the lack of business cases and business models. As big data fosters a new dimension
of value proposition in healthcare delivery, with insights on the effectiveness of
treatments to significantly improve the quality of care, new reimbursement models
that reward quality instead of quantity of treatments are needed.
Open Access This chapter is distributed under the terms of the Creative Commons Attribution-
Noncommercial 2.5 License (http://creativecommons.org/licenses/by-nc/2.5/) which permits any
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